Matt Hancock confirms dip in UK Covid vaccine supply for April

Health secretary says stocks will be affected by need to retest 1.7m doses and delay from India

Matt Hancock has said there will be a significant dip in vaccine supply in April, confirming supplies have been hit by a need to retest 1.7m doses and a delay in arrival of imports from India.

Speaking in the House of Commons, Hancock stressed the overall target timetable for vaccinations would not change but said he wanted to give more information, following the “speculation we’ve seen overnight”, after he was criticised for a press conference on Wednesday where the drop in supply went unexplained.

“In the last week, we’ve had a batch of 1.7m doses delayed because of the need to retest its stability,” he said. “Events like this are to be expected in a manufacturing endeavour of this complexity and this shows the rigour of our safety checks. And we have a delay in the scheduled arrival from the Serum Institute of India.”

However, speaking to the Guardian earlier, a source authorised to speak for the institute denied there was any delay in delivering vaccines, claiming there had been no agreed timeframe to deliver a second tranche of 5m doses.

The source said there had not been a hold-up from the Indian government, and that it had given approval for exports, though permission depended on the situation in India, which has significantly changed in the past fortnight.

Government sources also declined to clarify which vaccine batch had been affected by the need to retest supplies for stability.

The health secretary said that there would inevitably be some uncertainty in the manufacturing process. “The pace of rollout has always been determined by the availability of supply. The process of manufacturing vaccines is complicated, and subject to unpredictability,” he said.

“We make public commitments to the goals we can reach, according to our best estimates of future supply. That supply goes up and down.”

Hancock said the UK was currently experiencing “some bumper weeks of supply” but that would fall. The slowing of first doses would also come from the need to use the supply to administer second doses to meet the 12-week deadline, Hancock said.

“We have a huge number of second doses to deliver during April. Around 12 million people, including many colleagues in this house, will receive their second dose. These second doses cannot be delayed, as they have to be delivered within 12 weeks of the first dose.”

Hancock was at pains to praise the Serum Institute of India, as well as vaccine producers Pfizer and AstraZeneca, saying the institute was doing “incredible work” producing vaccines for the whole world.

“Their technology, and their capability, which has been approved by the MHRA, is remarkable. It truly is a partnership that we can be proud of,” he told MPs.

He said no appointments would be cancelled and that the targets were still on track to be met. “There will be no weeks in April with no first doses, there will be no cancelled appointments as a result of supply issues. Second doses will go ahead as planned.”

Hancock also announced that Gibraltar had become “the first nation in the world to complete its entire adult vaccination programme”, calling it a “success thanks to a team spirit across the British family of nations”.

After a slow start, India’s vaccination programme has more than doubled the number of doses it is administering each day compared with last week, which in turn is likely to have increased its demands on the institute’s supply.

Indian frontline workers wait to get inoculated with the Covid-19 coronavirus vaccine at a government hospital in Chennai.

Indian frontline workers wait to get inoculated with the Covid-19 coronavirus vaccine at a government hospital in Chennai.
Photograph: Arun Sankar/AFP/Getty Images

India has sold or gifted about 59m vaccine doses abroad, compared with the 37m it has administered at home, with another 38m distributed to state governments and awaiting use. Indians have largely backed their government’s programme of “vaccine maitri” (vaccine friendship), but the country’sforeign minister, S Jaishankar, told parliament on Wednesday that exports and donations were “based on the assessment of adequate availability at home”.

AstraZeneca has partnered with the institute, which is the world’s largest vaccine manufacturer, to supply the Indian government and other countries, including low- and middle-income ones.

A member of the UK government’s joint committee on vaccination and immunisation conceded on Thursday morning that Covid infections could rise as a result of the delay in people in their 40s and younger getting their vaccinations.

Adam Finn, who advises UK health departments on immunisation and is a professor of paediatrics at the University of Bristol, told BBC Radio 4’s Today programme that vaccination of those aged under 50 “may kick off slightly later than we’d optimistically hoped”.

Finn said the decline in hospital admissions should continue as long as all those over-50s and vulnerable people were vaccinated on time. He said the 12 weeks between first and second doses must “not be allowed to slip significantly”.

Contributors

Jessica Elgot and Michael Safi

The GuardianTramp

Related Content

Article image
Care home staff could be required to have Covid vaccine, says Matt Hancock
Health secretary announces consultation, but operators fear it could worsen staff shortages

Robert Booth Social affairs correspondent

14, Apr, 2021 @3:07 PM

Article image
Military will help distribute Covid-19 vaccine, says Hancock
Health secretary tells Tory conference a vaccine is the ‘great hope’ as he hails Covid app

Alexandra Topping and Lisa O'Carroll

04, Oct, 2020 @6:01 PM

Article image
UK Covid: 60m vaccine booster shots secured for use later this year – as it happened
Latest updates: Matt Hancock says UK has now secured 60m doses of Pfizer/BioNTech vaccine to be used for booster shots later this year

Andrew Sparrow

28, Apr, 2021 @5:23 PM

Article image
Covid vaccine could be ready for rollout next month, says Hancock
Health secretary says NHS is preparing for mass rollout but stresses ‘we’re not there yet’

Simon Murphy Political correspondent

10, Nov, 2020 @10:07 AM

Article image
NHS England staff should have Covid vaccine before winter, Hancock says
Former health secretary warns ministers against delaying mandatory jabs for health workers

Jamie Grierson

08, Nov, 2021 @8:17 AM

Article image
Vaccine supply is holding back jabs programme, says Matt Hancock
Health secretary says ‘getting vaccine out’ not the problem, as GPs reportedly pause inoculations

Caroline Davies

13, Jan, 2021 @10:30 AM

Article image
UK Covid: Matt Hancock plays down NHS warning of 'major contraction' in vaccine supply – as it happened
Health secretary says vaccine supply is always ‘lumpy’ after NHS warns first vaccine dose volumes ‘significantly constrained’

Andrew Sparrow

17, Mar, 2021 @6:36 PM

Article image
India variant will be dominant UK Covid strain ‘in next few days’
Scientists’ warning comes as government comes under pressure to explain border policy

Peter Walker, Nicola Davis and Jessica Elgot

17, May, 2021 @6:59 PM

Article image
Johnson & Johnson one-dose Covid vaccine shown to work
UK has bought 30m doses of product that could transform world’s immunisation programmes

Sarah Boseley Global health editor

29, Jan, 2021 @4:23 PM

Article image
Matt Hancock launches contact-tracing app with Isle of Wight trial
Concerns raised over privacy, but health secretary claims there is ‘huge enthusiasm’

Heather Stewart, Alex Hern and Denis Campbell

04, May, 2020 @6:38 PM